Provided by Tiger Trade Technology Pte. Ltd.

Lexicon Pharmaceuticals

2.02
-0.1300-6.05%
Post-market: 2.020.0046+0.23%17:06 EDT
Volume:2.94M
Turnover:5.98M
Market Cap:896.88M
PE:-12.73
High:2.14
Open:2.11
Low:2.01
Close:2.15
52wk High:2.68
52wk Low:1.06
Shares:444.00M
Float Shares:220.42M
Volume Ratio:1.68
T/O Rate:1.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1587
EPS(LYR):-0.1387
ROE:-40.21%
ROA:-14.32%
PB:5.14
PE(LYR):-14.57

Loading ...

Lexicon to Present at Citi Biopharma Back to School Investor Conference

Reuters
·
Sep 02

Why Lexicon Pharmaceuticals (LXRX) Is Back In The Spotlight

Simply Wall St.
·
Sep 01

Lexicon announces results from post hoc analysis of SOLOIST-WHF trial

TIPRANKS
·
Aug 31

Lexicon Post Hoc Soloist-WHF Analysis Shows Sotagliflozin Benefit Holds Across Baseline Blood Pressure Levels

Reuters
·
Aug 31

Analysts Have Conflicting Sentiments on These Healthcare Companies: Lexicon Pharmaceuticals (LXRX) and MaxCyte (MXCT)

TIPRANKS
·
Aug 24

Lexicon Pharma Earns $10 Million Milestone Payment from Novo Nordisk

Dow Jones
·
Aug 24

Lexicon earns third $10M milestone payment from Novo Nordisk for LX9851

TIPRANKS
·
Aug 24

Lexicon Pharmaceuticals Earns Third $10 Million Milestone Payment from Novo Nordisk Following Achievement of Key Phase 1 Development Milestone for Lx9851

THOMSON REUTERS
·
Aug 24

Lexicon Pharmaceuticals, - Has Earned $75 Mln of $1 Bln Potential Milestone Payments from Novo Nordisk

THOMSON REUTERS
·
Aug 24

Lexicon Pharmaceuticals, - Eligible for up to $1 Bln in Upfront and Milestone Payments Plus Royalties

THOMSON REUTERS
·
Aug 24

Quantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Progressive Multiple Sclerosis:

GlobeNewswire
·
Aug 10

Lexicon Pharmaceuticals (LXRX) Receives a Buy from Piper Sandler

TIPRANKS
·
Aug 07

Lexicon Pharmaceuticals - to Offer up to 1,257,856 Shares of Common Stock Issuable to Selling Stockholders - SEC Filing

THOMSON REUTERS
·
Aug 07

Lexicon Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Earnings Flash (LXRX) Lexicon Pharmaceuticals Posts Q2 Loss $0.07 a Share, vs. FactSet Est of $0.05 Loss

MT Newswires Live
·
Aug 06

Lexicon Pharmaceuticals Posts Q2 Net Loss

Reuters
·
Aug 06

Lexicon Pharmaceuticals Q2 EPS $(0.07) Misses $(0.05) Estimate, Sales $692.000K Miss $3.998M Estimate

Benzinga Earnings
·
Aug 06

Lexicon Q2 FY26 Net Loss Widens to $31.8 Million; Revenue Drops to $0.7 Million

Reuters
·
Aug 06

Lexicon Pharmaceuticals Q2 Basic EPS USD -0.07

THOMSON REUTERS
·
Aug 06

Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates

GlobeNewswire
·
Aug 06